Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. Almee™ (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. Using its unique expertise in ATRAG chemistry and biology, Vicore is further fueling its pipeline with several new therapies across additional potential indications. The company’s shares (VICO) are listed on Nasdaq Stockholm’s main market. For more information, see www.vicorepharma.com.
Company Details
- Employees
- 46
- Founded
- -
- Address
- Kornhamnstorg 53, Stockholm,stockholm County 111 27,sweden
- Phone
- +46 (0) 31 788 05 60
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- vicorepharma.com
- Keywords
- pharmaceutical development.
- HQ
- Stockholm, Stockholm County
Vicore Pharma Ab Questions
Vicore Pharma Ab's helpline number is +46 (0) 31 788 05 60
Vicore Pharma Ab's website is vicorepharma.com
Vicore Pharma Ab's LinkedIn profile is https://se.linkedin.com/company/vicore-pharma-ab
Vicore Pharma Ab has
46 employees.
View email and phone details for 46
employees at Vicore Pharma Ab.
Vicore Pharma Ab's industry is
Pharmaceutical Manufacturing
Vicore Pharma Ab's top competitors are
Bioarctic,
Sanofi,
Xbrane Biopharma Ab,
Egetis Therapeutics Ab,
Alex Therapeutics,
Pelago Bioscience Ab,
Unimedic Pharma Ab,
Pieris Pharmaceuticals,
Immedica Pharma Ab,
Alzecure Pharma.
Vicore Pharma Ab's categories are Pharmaceutical Manufacturing
Vicore Pharma Ab's founding year is 2009
